Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
HYTRIN
Generic name / active ingredient
terazosin hydrochloride capsules
Dosage-form class
Historical HYTRIN included immediate-release oral tablets and capsules. The exact package comparators currently shown are generic terazosin hydrochloride capsules. TEZRULY is a 1 mg/mL oral solution with a different form, concentration, application and measuring method; a shared ingredient does not permit self-conversion or substitution.
Route
Oral
Record reviewed
2026-09-02

Copy from the pack in hand

Source-linked reading points

  • Older adults, people with falls, those rising at night or using another blood-pressure medicine should have the full list, recent interruption and symptoms reviewed. Do not self-restart, increase, separate or stop a pack.
  • The label reports hypotension with PDE-5 inhibitors. If CIALIS, VIAGRA or a similar medicine is on the same list, do not self-design spacing or dose reductions.
  • Before cataract surgery, tell the eye team about current or previous terazosin/other alpha-1 blocker use; the label says self-stopping has not shown benefit.
  • Syncope or a fall with injury needs timely medical assessment. A painful erection lasting for hours is a rare but urgent labelled warning requiring immediate emergency care.

Reviewed presentation examples — compare every field

  • Terazosin 1 mg per capsule; 100-capsule bottle; current generic comparatorNDC 24689-001-01
  • Terazosin 2 mg per capsule; 100-capsule bottle; current generic comparatorNDC 24689-002-01
  • Terazosin 5 mg per capsule; 100-capsule bottle; current generic comparatorNDC 24689-003-01
  • Terazosin 10 mg per capsule; 100-capsule bottle; current generic comparatorNDC 24689-004-01

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-09-02
Source record
4 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image